Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- National Medical Costs in FY2002 Decline 0.6% to \31 Trillion
September 6, 2004
- OTC NEWS IN BRIEF
September 6, 2004
- Korosho to Steadily Implement Its Industry Visions: Mr Futagawa
September 6, 2004
- WORLD NEWS IN BRIEF
September 6, 2004
- Korosho to Work to Increase Speed, Reliability of NDA Review: Mr Kawahara
September 6, 2004
- Problems Remain with Large Hospitals, Chain Pharmacies: FJPWA Survey
September 6, 2004
- CDFS's Committee on Blood Programs Discusses Its Own Management Policy
September 6, 2004
- MONITOR
September 6, 2004
- REGULATORY NEWS IN BRIEF
September 6, 2004
- Iressa Shows 5.81% Incidence of Interstitial Pneumonia, Pulmonary Toxicity: Special Survey
September 6, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 6, 2004
- Sankyo to Drastically Reorganize Branch Offices
September 6, 2004
- Japanese Healthcare Q&A (10)
September 6, 2004
- Zeria Working to Strengthen Product Line-up in GI Field
September 6, 2004
- Profits Up for Top 10 Houses Despite 1.2% Decline in Sales
September 6, 2004
- Hokuyaku to Remain Regional Wholesalers Supporting Regional Med Institutions
September 6, 2004
- 1st Qtr Business Results
September 6, 2004
- Unfair Contracts Still Noted between Wholesalers and Med Institutions: Survey
September 6, 2004
- NEW PRODUCTS
September 6, 2004
- Thinking CRAs Needed: Quintiles Seminar
September 6, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…